Biochemical and neurophysiological investigations in two forms of Segawa's disease.
In two 14-year-old children with the typical clinical picture of Segawa's syndrome the metabolism of L-DOPA was examined and compared to an age matched control. The very different responses to DOPA- and benser-acid-medication underline the hypothesis, that Segawa's disease may result from at least two different pathological conditions. Since this disease mimics hereditary degenerative nervous tissue disorders, evoked potentials of both patients are demonstrated, showing that those pathways of the CNS, who can be examined by these methods, are unaffected.
Görke
W
W
University Children's Hospital, Bochum, FRG.
Bartholomé
K
K
D000293:Adolescent; D001480:Basal Ganglia Diseases / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology*; D001545:Benserazide / Q000097:blood / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004421:Dystonia / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology; D005071:Evoked Potentials / Q000187:drug effects; D005260:Female; D006801:Humans; D007980:Levodopa / Q000097:blood / Q000627:therapeutic use; D008297:Male; D013577:Syndrome; D014446:Tyrosine 3-Monooxygenase / Q000172:deficiency
D007980:Levodopa; D001545:Benserazide; D014446:Tyrosine 3-Monooxygenase